Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 2
1992 2
1993 2
1994 4
1995 1
1996 2
1997 2
1998 6
1999 3
2000 7
2001 1
2002 8
2003 5
2004 12
2005 11
2006 9
2007 4
2008 9
2009 7
2010 9
2011 17
2012 11
2013 15
2014 9
2015 11
2016 7
2017 2
2018 8
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 20378644

171 results
Results by year
Filters applied: . Clear all
Page 1
Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease.
Foley RN, Curtis BM, Randell EW, Parfrey PS. Foley RN, et al. Clin J Am Soc Nephrol. 2010 May;5(5):805-13. doi: 10.2215/CJN.07761109. Epub 2010 Apr 8. Clin J Am Soc Nephrol. 2010. PMID: 20378644 Free PMC article. Clinical Trial.
Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
Thanakitcharu P, Siriwiwatanakul N. Thanakitcharu P, et al. J Med Assoc Thai. 2007 Dec;90(12):2574-86. J Med Assoc Thai. 2007. PMID: 18386706
Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
Massimetti C, Pontillo D, Feriozzi S, Costantini S, Capezzuto A, Ancarani E. Massimetti C, et al. Blood Purif. 1998;16(6):317-24. doi: 10.1159/000014351. Blood Purif. 1998. PMID: 10343078
Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.
Patel RK, Oliver S, Mark PB, Powell JR, McQuarrie EP, Traynor JP, Dargie HJ, Jardine AG. Patel RK, et al. Clin J Am Soc Nephrol. 2009 Sep;4(9):1477-1483. doi: 10.2215/CJN.03350509. Clin J Am Soc Nephrol. 2009. PMID: 19713289 Free PMC article.
Italian randomized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease.
Cianciaruso B, Ravani P, Barrett BJ, Levin A; ITA-EPO-7 investigators. Cianciaruso B, et al. J Nephrol. 2008 Nov-Dec;21(6):861-70. J Nephrol. 2008. PMID: 19034870 Clinical Trial.
Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Unver S, Kavlak E, Gümüsel HK, Celikbilek F, Esertas K, Muftuoglu T, Kirilmaz A. Unver S, et al. Ren Fail. 2015 Jul;37(6):951-6. doi: 10.3109/0886022X.2015.1052945. Epub 2015 Jun 1. Ren Fail. 2015. PMID: 26030798
[Improvement of left ventricular hypertrophy by anemic-correcting erythropoietin therapy in chronic renal insufficiency].
Jiang JP, Hou FF, Gao LZ, Pan YB, Yang NS, Chen W, Shu GY, Chen YM, Chen J, Peng WH, Wu JP, Yang ZM. Jiang JP, et al. Zhonghua Nei Ke Za Zhi. 2005 Jan;44(1):25-9. Zhonghua Nei Ke Za Zhi. 2005. PMID: 15769393 Chinese.
Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
Higuchi T, Abe M, Yamazaki T, Okawa E, Ando H, Hotta S, Oikawa O, Kikuchi F, Okada K, Soma M. Higuchi T, et al. Am J Kidney Dis. 2016 Feb;67(2):260-70. doi: 10.1053/j.ajkd.2015.09.010. Epub 2015 Oct 23. Am J Kidney Dis. 2016. PMID: 26508680 Clinical Trial.
Contribution of anemia and hypertension to left ventricular hypertrophy during the initial 2 years after renal transplantation.
Ibernon M, Moreso F, Ruiz-Majoral A, Sarrias X, Sarrias M, Grinyó JM, Serón D. Ibernon M, et al. Transplant Proc. 2011 Jul-Aug;43(6):2199-204. doi: 10.1016/j.transproceed.2011.05.006. Transplant Proc. 2011. PMID: 21839233
Effects of optimized heart failure therapy and anemia correction with epoetin beta on left ventricular mass in hemodialysis patients.
Hampl H, Hennig L, Rosenberger C, Amirkhalily M, Gogoll L, Riedel E, Scherhag A. Hampl H, et al. Am J Nephrol. 2005 May-Jun;25(3):211-20. doi: 10.1159/000085881. Epub 2005 May 18. Am J Nephrol. 2005. PMID: 15900093
171 results
Jump to page
Feedback